169 related articles for article (PubMed ID: 29777361)
41. Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity.
Fukudo M; Yano I; Masuda S; Okuda M; Inui K
J Pharmacol Exp Ther; 2005 Feb; 312(2):816-25. PubMed ID: 15383634
[TBL] [Abstract][Full Text] [Related]
42. Unusual case of tacrolimus vascular toxicity after deceased donor renal transplantation.
Sugitani A; Takahashi C; Naka T; Hisamitsu K; Yamamoto O; Taniguchi K; Kobayashi N; Kimura M; Yoshida H; Hamazoe R
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():60-2. PubMed ID: 27004749
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
[TBL] [Abstract][Full Text] [Related]
45. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
[TBL] [Abstract][Full Text] [Related]
46. A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.
Zaghla H; Selby RR; Chan LS; Kahn JA; Donovan JA; Jabbour N; Genyk Y; Mateo R; Gagandeep S; Sher LS; Ramicone E; Fong TL
Aliment Pharmacol Ther; 2006 Feb; 23(4):513-20. PubMed ID: 16441472
[TBL] [Abstract][Full Text] [Related]
47. Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.
Renders L; Steinbach R; Valerius T; Schöcklmann HO; Kunzendorf U
Kidney Blood Press Res; 2004; 27(3):181-5. PubMed ID: 15256815
[TBL] [Abstract][Full Text] [Related]
48. Relationship between hemorheology and endothelial dysfunction in renal transplant patients receiving calcineurin inhibitors.
Akoglu H; Seringec N; Yildirim T; Yilmaz R; Okutucu S; Turkmen E; Evranos B; Kaya EB; Dikmenoglu N; Arici M; Erdem Y; Turgan C
J Nephrol; 2013; 26(5):931-40. PubMed ID: 23147686
[TBL] [Abstract][Full Text] [Related]
49. Tacrolimus for the prevention and treatment of rejection of solid organ transplants.
Scalea JR; Levi ST; Ally W; Brayman KL
Expert Rev Clin Immunol; 2016; 12(3):333-42. PubMed ID: 26588770
[TBL] [Abstract][Full Text] [Related]
50. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
51. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus.
de Sandes-Freitas TV; Felipe CR; Campos ÉF; de Lima MG; Soares MF; de Franco MF; Aguiar WF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2015 Nov; 99(11):2372-81. PubMed ID: 25929604
[TBL] [Abstract][Full Text] [Related]
52. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
Weir MR; Pearson TC; Patel A; Peddi VR; Kalil R; Scandling J; Chan L; Baliga P; Melton L; Mulgaonkar S; Waid T; Schaefer H; Youssef N; Anandagoda L; McCollum D; Lawson S; Gordon R
Transplantation; 2017 Jan; 101(1):157-165. PubMed ID: 26950714
[TBL] [Abstract][Full Text] [Related]
53. Tacrolimus Toxicity With Minimal Clinical Manifestations: A Case Report and Literature Review.
Haroon N; Singh A; Bhat ZY
Am J Ther; 2016; 23(2):e631-4. PubMed ID: 25730156
[TBL] [Abstract][Full Text] [Related]
54. Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients.
Pulzer A; Seybold U; Schönermarck U; Stangl M; Habicht A; Bogner JR; Franke J; Fischereder M
Transpl Int; 2013 Mar; 26(3):254-8. PubMed ID: 23227980
[TBL] [Abstract][Full Text] [Related]
55. Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences.
Shrestha BM
Exp Clin Transplant; 2017 Feb; 15(1):1-9. PubMed ID: 27938316
[TBL] [Abstract][Full Text] [Related]
56. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
[TBL] [Abstract][Full Text] [Related]
57. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
58. Sirolimus and secondary skin-cancer prevention in kidney transplantation.
Euvrard S; Morelon E; Rostaing L; Goffin E; Brocard A; Tromme I; Broeders N; del Marmol V; Chatelet V; Dompmartin A; Kessler M; Serra AL; Hofbauer GF; Pouteil-Noble C; Campistol JM; Kanitakis J; Roux AS; Decullier E; Dantal J;
N Engl J Med; 2012 Jul; 367(4):329-39. PubMed ID: 22830463
[TBL] [Abstract][Full Text] [Related]
59. Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.
Hsu KH; Chou NK; Tsai MK; Chi NH; Chen YS; Yu HY; Wang CH; Ko WJ; Tsao CI; Lee PH; Wang SS
Transplant Proc; 2010 Apr; 42(3):934-7. PubMed ID: 20430208
[TBL] [Abstract][Full Text] [Related]
60. The effect of maintenance immunosuppression medication on the change in kidney allograft function.
Gill JS; Tonelli M; Mix CH; Johnson N; Pereira BJ
Kidney Int; 2004 Feb; 65(2):692-9. PubMed ID: 14717943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
